Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no substantive study content, endpoints, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision label changed from v3.4.0 to v3.4.1 with no impact on content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded standalone 'Results First Posted' and 'Last Update Posted' timestamps and removed the '(Estimated)' qualifiers for those fields. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded results-related sections (Best Overall Response Rate; Results First Submitted/Posted; Results Reporting Dates; Last Update Posted (Estimated)) and expanded site locations to include New Jersey and New York. Also added the Study Protocol and Statistical Analysis Plan PDF (Revision v3.3.3, 2024-05-03) and removed older entries such as the standalone New Jersey/Ny Locations and earlier Best Overall Response Rate entries.SummaryDifference2%

- Check77 days agoChange DetectedThe page changed from showing 'No Results Posted' to 'Results Submitted', indicating that results have been submitted for posting.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.